home / stock / pfnx / pfnx quote
Last: | $12.75 |
---|---|
Change Percent: | -0.08% |
Open: | $12.74 |
Close: | $12.75 |
High: | $12.94 |
Low: | $12.74 |
Volume: | 1,616,228 |
Last Trade Date Time: | 09/30/2020 04:56:25 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$12.75 | $12.74 | $12.75 | $12.94 | $12.74 | 1,616,228 | 09-30-2020 |
$12.76 | $12.86 | $12.76 | $12.86 | $12.73 | 8,086,058 | 09-29-2020 |
$12.69 | $12.68 | $12.69 | $12.71 | $12.66 | 566,884 | 09-25-2020 |
$12.69 | $12.7 | $12.69 | $12.73 | $12.66 | 1,325,745 | 09-24-2020 |
$12.71 | $12.72 | $12.71 | $12.78 | $12.7 | 605,416 | 09-23-2020 |
$12.86 | $12.69 | $12.86 | $12.86 | $12.68 | 599,355 | 09-22-2020 |
$12.68 | $12.68 | $12.68 | $12.74 | $12.66 | 554,896 | 09-21-2020 |
$12.75 | $12.7 | $12.75 | $12.75 | $12.66 | 1,486,974 | 09-18-2020 |
$12.7 | $12.66 | $12.7 | $12.75 | $12.66 | 186,417 | 09-17-2020 |
$12.69 | $12.75 | $12.69 | $12.76 | $12.69 | 818,088 | 09-16-2020 |
$12.7 | $12.73 | $12.7 | $12.76 | $12.69 | 642,646 | 09-15-2020 |
$12.71 | $12.72 | $12.71 | $12.78 | $12.66 | 560,820 | 09-14-2020 |
$12.7 | $12.67 | $12.7 | $12.78 | $12.65 | 197,597 | 09-11-2020 |
$12.71 | $12.74 | $12.71 | $12.77 | $12.595 | 342,814 | 09-10-2020 |
$12.66 | $12.6 | $12.66 | $12.71 | $12.6 | 284,957 | 09-09-2020 |
$12.63 | $12.6 | $12.63 | $12.7 | $12.6 | 190,499 | 09-08-2020 |
$12.69 | $12.85 | $12.69 | $12.87 | $12.6 | 292,629 | 09-07-2020 |
$12.69 | $12.85 | $12.69 | $12.87 | $12.6 | 292,629 | 09-04-2020 |
$12.88 | $12.55 | $12.88 | $12.95 | $12.55 | 941,933 | 09-03-2020 |
$12.61 | $12.59 | $12.61 | $12.65 | $12.53 | 508,750 | 09-02-2020 |
News, Short Squeeze, Breakout and More Instantly...
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that its tender offer to purchase any and all issued and outstanding shares of common stock of Pfenex Inc. (NYSE American: PFNX) at an offer price of $12.00 per share in cash, plus one non-transferable contractua...
NEW YORK, NY / ACCESSWIRE / September 15, 2020 / Juan Monteverde , founder, and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Pfenex Inc. (NYSE American: PFNX ) relating to it...
NEW YORK, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may ultimately s...